Clinical trials recruiting for SGLT2-Inhibitors
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Metformin | 1 |
| Tofogliflozin | 1 |
Self-screener
Recruiting trials
- Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients
- Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)
Related conditions
Trials recruiting for SGLT2-Inhibitors often also study these conditions. Each links to its own recruiting-trial list.
Type 2 diabetes 891T2DM (Type 2 Diabetes Mellitus) 7Heart Failure Preserved Ejection Fraction 4Heart failure 1021Diabetes (DM) 12Chronic kidney disease 588
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for SGLT2-Inhibitors trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.